RadNet, Inc., a national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States, announced it has acquired a 75% interest in London-based Heart & Lung Imaging Limited (HLI) for an undisclosed price.
HLI’s network of more than 70 expert cardiothoracic radiologists provides specialist reporting services for the U.K.’s National Health Service (NHS) as well as a variety of hospitals and academic institutions. Of particular note, HLI has established itself as the leading provider of lung cancer screening reporting services to the NHS England Targeted Lung Health Check program.
RadNet, Inc. is a national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. RadNet has a network of 353 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey and New York.
According to LevinPro HC, this marks the 109th transaction in the Laboratories, MRI and Dialysis sector this year, and the 60th deal in the diagnosis subsector. This also marks RadNet’s third acquisition since December 2021.
